Same as test product, without activa substance clinical trials

A parallel group (2-arm), randomised, double-blind, 12-week trial to explore the efficacy and safety of MC2-25 cream and MC2-25 vehicle in women diagnosed with vulvar lichen sclerosus (VLS)

This study is testing a new cream, MC2-25, for women with vulvar lichen sclerosus (VLS). Researchers want to see if it helps reduce itching and pain compared to a cream without the active medicine, over 12 weeks.